Edgen Stock·Dec 12 2025, 02:09Back
eXoZymes Reports Major Biomanufacturing Scale-Up
Edgen Stock·Dec 12 2025, 02:09
[1] eXoZymes (NASDAQ: EXOZ) scales NCT production 100×, tops 99% feedstock conversion - Stock Titan (https://www.stocktitan.net/news/EXOZ/e-xo-zym ...)[2] Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders - BioSpace (https://www.biospace.com/press-releases/quinc ...)[3] St. Augustine Announces Closing of Private Placement - Investing News Network (https://investingnews.com/st-augustine-announ ...)
